{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:CD8",
      "entity_text" : "CD8",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:PARP",
      "entity_text" : "PARP",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In this study, we demonstrate that PARP inhibition elicits an antitumor immune response in Brca1 deficient ovarian tumors by induction of both intratumoral and peripheral effector CD4 + and CD8 + T cells.",
  "reading_complete" : "2020-08-09T05:44:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T05:42:27Z",
  "trigger" : "elicits",
  "evidence" : [ "PARP inhibition elicits an antitumor immune response in Brca1-deficient ovarian tumors by induction of both intratumoral and peripheral effector CD4 +  and CD8" ],
  "pmc_id" : "6366450",
  "score" : 0
}